Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer

Geewon Lee, So Hyeon Bak, Ho Yun Lee, Joon Young Choi, Hyunjin Park, Seung Hak Lee, Yoshiharu Ohno, Mizuki Nishino, Edwin J.R. Van Beek, Kyung Soo Lee

Research output: Contribution to journalReview articlepeer-review

15 Citations (Scopus)


Multimodality imaging measurements of treatment response are critical for clinical practice, oncology trials, and the evaluation of new treatment modalities. The current standard for determining treatment response in non-small cell lung cancer (NSCLC) is based on tumor size using the RECIST criteria. Molecular targeted agents and immunotherapies often cause morphological change without reduction of tumor size. Therefore, it is difficult to evaluate therapeutic response by conventional methods. Radiomics is the study of cancer imaging features that are extracted using machine learning and other semantic features. This method can provide comprehensive information on tumor phenotypes and can be used to assess therapeutic response in this new age of immunotherapy. Delta radiomics, which evaluates the longitudinal changes in radiomics features, shows potential in gauging treatment response in NSCLC. It is well known that quantitative measurement methods may be subject to substantial variability due to differences in technical factors and require standardization. In this review, we describe measurement variability in the evaluation of NSCLC and the emerging role of radiomics.

Original languageEnglish
Pages (from-to)103-115
Number of pages13
JournalJournal of Thoracic Imaging
Issue number2
Publication statusPublished - 01-03-2019
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this